{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:55:32Z","timestamp":1791860132876,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1111\/ajt.16718","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T10:19:25Z","timestamp":1623493165000},"page":"3449-3455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study"],"prefix":"10.1016","volume":"21","author":[{"given":"Tobias","family":"Veit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5471-578X","authenticated-orcid":false,"given":"Dieter","family":"Munker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2914-8773","authenticated-orcid":false,"given":"Katrin","family":"Milger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Kauke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Meiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Nitschko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver T.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7583-0453","authenticated-orcid":false,"given":"Nikolaus","family":"Kneidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/ajt.16718_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.TP.0000165430.65645.4F","article-title":"Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations","volume":"80","author":"Zamora","year":"2005","journal-title":"Transplant."},{"issue":"5","key":"10.1111\/ajt.16718_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy","volume":"85","author":"Harvala","year":"2013","journal-title":"J Med Virol."},{"issue":"4","key":"10.1111\/ajt.16718_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hemonc.2017.05.001","article-title":"Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation","volume":"10","author":"Camargo","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther."},{"issue":"4","key":"10.1111\/ajt.16718_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.athoracsur.2018.10.034","article-title":"Long-term impact of cytomegalovirus serologic status on lung transplantation in the United States","volume":"107","author":"Kurihara","year":"2019","journal-title":"Ann Thorac Surg."},{"issue":"28","key":"10.1111\/ajt.16718_bib5","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.2174\/1381612826666200531152901","article-title":"Cytomegalovirus in solid organ transplant recipients: clinical updates, challenges and future directions","volume":"26","author":"Razonable","year":"2020","journal-title":"Curr Pharm Des."},{"issue":"6","key":"10.1111\/ajt.16718_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplant."},{"issue":"1","key":"10.1111\/ajt.16718_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ajt.15581","article-title":"Lung transplant outcomes are influenced by severity of neutropenia and granulocyte colony-stimulating factor treatment","volume":"20","author":"Tague","year":"2020","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.16718_bib8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/cid\/ciy696","article-title":"Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials","volume":"68","author":"Chemaly","year":"2019","journal-title":"Clin Infect Dis."},{"issue":"10","key":"10.1111\/ajt.16718_bib9","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/TP.0000000000001418","article-title":"Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection","volume":"100","author":"Avery","year":"2016","journal-title":"Transplant."},{"issue":"25","key":"10.1111\/ajt.16718_bib10","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.16718_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1600-6143.2011.03530.x","article-title":"First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246","volume":"11","author":"Kaul","year":"2011","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.16718_bib12","doi-asserted-by":"crossref","first-page":"e12965","DOI":"10.1111\/tid.12965","article-title":"Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation)","volume":"20","author":"Chong","year":"2018","journal-title":"Transpl Infect Dis."},{"issue":"1","key":"10.1111\/ajt.16718_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/tri.12225","article-title":"Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study","volume":"27","author":"Stoelben","year":"2014","journal-title":"Transpl Int."},{"issue":"2","key":"10.1111\/ajt.16718_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0000000000002886","article-title":"Letermovir for difficult to treat cytomegalovirus infection in lung transplant recipients","volume":"104","author":"Veit","year":"2020","journal-title":"Transplant."},{"issue":"2","key":"10.1111\/ajt.16718_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/TP.0000000000002785","article-title":"Letermovir as salvage therapy for cytomegalovirus infection in transplant recipients","volume":"104","author":"Phoompoung","year":"2020","journal-title":"Transplant."},{"issue":"6","key":"10.1111\/ajt.16718_bib16","doi-asserted-by":"crossref","first-page":"e13166","DOI":"10.1111\/tid.13166","article-title":"Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients","volume":"21","author":"Aryal","year":"2019","journal-title":"Transpl Infect Dis."},{"issue":"3","key":"10.1111\/ajt.16718_bib17","doi-asserted-by":"crossref","first-page":"e02337","DOI":"10.1128\/AAC.02337-18","article-title":"Use of letermovir as salvage therapy for drug-resistant cytomegalovirus retinitis","volume":"63","author":"Turner","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"issue":"12","key":"10.1111\/ajt.16718_bib18","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1111\/ajt.15135","article-title":"Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection","volume":"18","author":"Cherrier","year":"2018","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.16718_bib19","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1097\/TP.0000000000003260","article-title":"Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient","volume":"104","author":"Kronig","year":"2020","journal-title":"Transplant."},{"key":"10.1111\/ajt.16718_bib20","unstructured":"Linder K, Kovacs K, Mullane KM, et al. Letermovir treatment for established CMV infection in transplant recipients. American Transplant Congress. 2020. Available at: https:\/\/atcmeetingabstracts.com\/abstract\/letermovir-treatmentfor-established-cytomegalovirus-infection-in-transplant-recipients\/. Accessed 1 September 2020."},{"issue":"4","key":"10.1111\/ajt.16718_bib21","doi-asserted-by":"crossref","first-page":"1601315","DOI":"10.1183\/13993003.01315-2016","article-title":"Lung volumes predict survival in patients with chronic lung allograft dysfunction","volume":"49","author":"Kneidinger","year":"2017","journal-title":"Eur Respir J."},{"issue":"6","key":"10.1111\/ajt.16718_bib22","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/ajt.15251","article-title":"A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation","volume":"19","author":"Gottlieb","year":"2019","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.16718_bib23","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"\u00c5sberg","year":"2007","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.16718_bib24","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"issue":"23","key":"10.1111\/ajt.16718_bib25","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients","volume":"128","author":"El Chaer","year":"2016","journal-title":"Blood."},{"key":"10.1111\/ajt.16718_bib26","unstructured":"Marty FM, Alexander B, Brissot E, et al. A phase 3 randomized study of maribavir (MBV) versus investigator-assigned antiviral therapy (IAT) for the treatment (Tx) of refractory\/resistant (R\/R) cytomegalovirus (CMV) infection in hematopoietic cell transplant (HCT) or solid organ transplant (SOT) recipients; 2021. Abstract LBA2. https:\/\/tct.confex.com\/tct\/2021\/meetingapp.cgi\/Paper\/18096. Accessed 2 June 2021."},{"key":"10.1111\/ajt.16718_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2019.01.011","article-title":"Clinical development of letermovir and maribavir: overview of human cytomegalovirus drug resistance","volume":"163","author":"Piret","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1111\/ajt.16718_bib28","first-page":"ciaa1713","article-title":"Letermovir and maribavir for the treatment and prevention of cytomegalovirus infection in solid organ and stem cell transplant recipients","volume":"17","author":"Imlay","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"10","key":"10.1111\/ajt.16718_bib29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/jcph.1423","article-title":"Pharmacokinetic drug-drug interactions between letermovir and the immunosuppressants cyclosporine, tacrolimus, sirolimus, and mycophenolate mofetil","volume":"59","author":"McCrea","year":"2019","journal-title":"J Clin Pharmacol."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16718","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16718","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522087640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522087640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:33:46Z","timestamp":1761629626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522087640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1600613522087640"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16718","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}